These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 31545414

  • 1. MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma.
    Deng J, Wang W, Yu G, Ma X.
    Mol Med Rep; 2019 Nov; 20(5):4023-4032. PubMed ID: 31545414
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA‑195 suppresses rectal cancer growth and metastasis via regulation of the PI3K/AKT signaling pathway.
    Wang Y, Mu L, Huang M.
    Mol Med Rep; 2019 Nov; 20(5):4449-4458. PubMed ID: 31702045
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
    Zhang H, Wang X, Chen Z, Wang W.
    Cell Mol Biol (Noisy-le-grand); 2015 Nov 30; 61(7):96-101. PubMed ID: 26638889
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
    Shan H, Zhou X, Chen C.
    Mol Med Rep; 2019 Aug 30; 20(2):1459-1467. PubMed ID: 31173203
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F, Liang A, Lv Y, Liu G, Jiang A, Liu P.
    Med Sci Monit; 2017 Oct 28; 23():5139-5149. PubMed ID: 29080395
    [Abstract] [Full Text] [Related]

  • 6. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S, Wang M, Li Q, Zhu P.
    Cancer Biomark; 2017 Dec 12; 21(1):179-186. PubMed ID: 29081412
    [Abstract] [Full Text] [Related]

  • 7. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 12; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 8. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
    Xin W, Zhao S, Han X, Zhao P, Yu H, Gao X, Li P, Wu Q, Ding J, Hua K.
    Int J Oncol; 2020 Jul 12; 57(1):355-363. PubMed ID: 32319598
    [Abstract] [Full Text] [Related]

  • 9. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X, Guo R, Qiao Y, Zhang Y, Lei J, Wang X, Li L, Hu D.
    Int J Gynecol Cancer; 2013 Jan 12; 23(1):52-9. PubMed ID: 23235274
    [Abstract] [Full Text] [Related]

  • 10. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.
    Fan Y, Dong Z, Shi Y, Sun S, Wei B, Zhan L.
    J Int Med Res; 2020 May 12; 48(5):300060520925352. PubMed ID: 32431202
    [Abstract] [Full Text] [Related]

  • 11. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
    Wan J, Qin J, Cao Q, Hu P, Zhong C, Tu C.
    Genes Genomics; 2020 Mar 12; 42(3):317-324. PubMed ID: 31872384
    [Abstract] [Full Text] [Related]

  • 12. eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition.
    Zhang HH, Li R, Li YJ, Yu XX, Sun QN, Li AY, Kong Y.
    Oncol Rep; 2020 Feb 12; 43(2):447-460. PubMed ID: 31894279
    [Abstract] [Full Text] [Related]

  • 13. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y.
    Oncol Rep; 2012 Feb 12; 27(2):504-10. PubMed ID: 22075757
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
    Chen S, Chen X, Sun KX, Xiu YL, Liu BL, Feng MX, Sang XB, Zhao Y.
    PLoS One; 2016 Feb 12; 11(11):e0165776. PubMed ID: 27829043
    [Abstract] [Full Text] [Related]

  • 15. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
    Fan Y, Wang K.
    Mol Med Rep; 2020 Aug 12; 22(2):633-642. PubMed ID: 32467998
    [Abstract] [Full Text] [Related]

  • 16. Long non‑coding RNA SNHG12 regulates cell proliferation, invasion and migration in endometrial cancer by targeting miR‑4429.
    Cai P, Wu M, Zhang B, Wu S, Wei H, Wei L.
    Mol Med Rep; 2020 Oct 12; 22(4):2842-2850. PubMed ID: 32945395
    [Abstract] [Full Text] [Related]

  • 17. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B, Feng Y, Sun Y, Ji D, Qian W, Zhang Z, Wang Q, Zhang Y, Zhang C, Sun Y.
    Oncol Rep; 2018 Oct 12; 40(4):1885-1896. PubMed ID: 30066935
    [Abstract] [Full Text] [Related]

  • 18. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
    Li Y, Jia Y, Bian Y, Tong H, Qu J, Wang K, Wan XP.
    Cell Commun Signal; 2019 Mar 05; 17(1):22. PubMed ID: 30836961
    [Abstract] [Full Text] [Related]

  • 19. TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation.
    Xie BY, Lv QY, Ning CC, Yang BY, Shan WW, Cheng YL, Gu C, Luo XZ, Zhang ZB, Chen XJ, Xi XW, Feng YJ.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):857-862. PubMed ID: 27889612
    [Abstract] [Full Text] [Related]

  • 20. miR-195 suppresses abdominal aortic aneurysm through the TNF-α/NF-κB and VEGF/PI3K/Akt pathway.
    Ma X, Yao H, Yang Y, Jin L, Wang Y, Wu L, Yang S, Cheng K.
    Int J Mol Med; 2018 Apr 22; 41(4):2350-2358. PubMed ID: 29393364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.